Why is the screening rate in lung cancer still low? A seven-country analysis of the factors affecting adoption by Charlotte Poon, Tim Wilsdon, Iqra Sarwar, Alexander Roediger, Megan Yuan

Connect to this object online.

Accelerating patient access to oncology medicines with multiple indications in Europe by R. Lawlor, T. Wilsdon, E. Darquennes, D. Hemelsoet, J. Huismans, R. Normand, A. Roediger

Connect to this object online.

Releasing fast and slow: Non-destructive prediction of density and drug release from SLS 3D printed tablets using NIR spectroscopy by Sarah J. Trenfield, Xiaoyan Xu, Alvaro Goyanes, Martin Rowland, David Wilsdon, Simon Gaisford, Abdul W. Basit

Connect to this object online.

Prediction of Solid-State Form of SLS 3D Printed Medicines Using NIR and Raman Spectroscopy by Sarah J. Trenfield, Patricija Januskaite, Alvaro Goyanes, David Wilsdon, Martin Rowland, Simon Gaisford, Abdul W. Basit

Connect to this object online.

An international comparative analysis and roadmap to sustainable biosimilar markets by Khalid A. Alnaqbi, Agnès Bellanger, Alex Brill, Gilberto Castañeda-Hernández, Ana Clopés Estela, Olga Delgado Sánchez, Pilar García-Alfonso, Pius Gyger, Daniel Heinrich, Germain Hezard, Adriana Kakehasi, Cheryl Koehn, Olivier Mariotte, Francesco Mennini, Sonia Mayra Pérez-Tapia, Michele Pistollato, Rowan Saada, Tadanori Sasaki, George Tambassis, Marc Thill, Gustavo Werutsky, Tim Wilsdon, Steven Simoens

Connect to this object online.